SOPHARMA AD hereby informs that from 30 October 2014 up to and including 05 November 2014 the Company bought 1 000 own shares representing 0.0008% of the share capital of the Company, to the total value of 3 900 BGN on the Bulgarian Stock Exchange, the average price per share was 3.90 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 107 052, representing 3.87% of the share capital of the Company.

Sopharma AD (the “Company”) notifies that on 7 November 2014 the Financial Supervision Commission approved the Contract for transformation through merger and two additional annexes to it, signed on 19 June 2014 between Sopharma AD, Sofia, UIC 831902088, hereinafter referred to as "Acquirer" and Bulgarian Rose – Sevtopolis AD, Kazanlak, UIC 123007916, hereinafter referred to as "Acquiree" in accordance with the requirements of art. 262d and following of the Commercial Act (CA).

SOPHARMA AD hereby informs that from 6 November 2014 up to and including 12 November 2014 the Company bought 2 100 own shares representing 0.0015% of the share capital of the Company, to the total value of 8 201.8 BGN on the Bulgarian Stock Exchange, the average price per share was 3.91 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 109 152, representing 3.87% of the share capital of the Company.

SOPHARMA AD hereby informs that from 13 November 2014 up to and including 19 November 2014 the Company bought 300 own shares representing 0.0002% of the share capital of the Company, to the total value of 1109.8 BGN on the Bulgarian Stock Exchange, the average price per share was 3.70 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 109 452, representing 3.87% of the share capital of the Company.

SOPHARMA AD hereby informs that from 20 November 2014 up to and including 26 November 2014 the Company bought 1 211 own shares representing 0.0009% of the share capital of the Company, to the total value of 4 479.49 BGN on the Bulgarian Stock Exchange, the average price per share was 3.70 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 110 663, representing 3.87% of the share capital of the Company.

SOPHARMA AD hereby informs that from 27 November 2014 up to and including 3 December 2014 the Company bought 2 180 own shares representing 0.0017% of the share capital of the Company, to the total value of 8 285.7 BGN on the Bulgarian Stock Exchange, the average price per share was 3.80 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 112 843, representing 3.87% of the share capital of the Company.

Sopharma AD notifies that for November 2014 the Company recorded a decrease of sales revenues of 7% compared to the same month of 2013, including 4% increase of domestic sales and 11% decrease of export sales. During the past eleven months Sopharma AD recorded a decrease of sales revenues of 4%, including 4% increase of domestic sales and 7% decrease of export sales compared to the same period of 2013.

SOPHARMA AD hereby informs that from 4 December 2014 up to and including 10 December 2014 the Company bought 200 own shares representing 0.00015% of the share capital of the Company, to the total value of 796 BGN on the Bulgarian Stock Exchange, the average price per share was 3.98 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 113 043, representing 3.87% of the share capital of the Company.

SOPHARMA AD hereby informs that from 11 December 2014 up to and including 17 December 2014 the Company bought 510 own shares representing 0.00039% of the share capital of the Company, to the total value of 1964.01 BGN on the Bulgarian Stock Exchange, the average price per share was 3.85 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 113 553, representing 3.87% of the share capital of the Company.

Sopharma AD (the “Company”) notifies that on the regular General Meeting of Shareholders of Sopharma AD, conducted on 20 June 2014 in Sofia, 5 Lachezar Stanchev Str., were taken the following decisions: